These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8419169

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O, Hammache D, Fantini J, Yahi N.
    Biochemistry; 1996 Dec 10; 35(49):15663-71. PubMed ID: 8961929
    [Abstract] [Full Text] [Related]

  • 4. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X, Gaubin M, Briant L, Srikantan V, Murali R, Saragovi U, Weiner D, Devaux C, Autiero M, Piatier-Tonneau D, Greene MI.
    Nat Biotechnol; 1997 Feb 10; 15(2):150-4. PubMed ID: 9035140
    [Abstract] [Full Text] [Related]

  • 5. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R, Decroly E, Kieny MP, Fenouillet E.
    Virology; 2000 Jul 20; 273(1):169-77. PubMed ID: 10891419
    [Abstract] [Full Text] [Related]

  • 6. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
    Zanotto C, Calderazzo F, Dettin M, Di Bello C, Autiero M, Guardiola J, Chieco-Bianchi L, De Rossi A.
    Virology; 1995 Feb 01; 206(2):807-16. PubMed ID: 7856094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML, Arthos J, Guichou JF, McNally J, Cicala C, Arold ST.
    J Mol Biol; 2008 Feb 01; 375(5):1320-8. PubMed ID: 18078954
    [Abstract] [Full Text] [Related]

  • 11. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.
    Kalyanaraman VS, Rausch DM, Osborne J, Padgett M, Hwang KM, Lifson JD, Eiden LE.
    J Immunol; 1990 Dec 15; 145(12):4072-8. PubMed ID: 1701782
    [Abstract] [Full Text] [Related]

  • 12. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B, Treboute C, Brelot A, Alizon M.
    J Virol; 2001 Jun 15; 75(12):5457-64. PubMed ID: 11356952
    [Abstract] [Full Text] [Related]

  • 13. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W, Canziani G, Plugariu C, Wyatt R, Sodroski J, Sweet R, Kwong P, Hendrickson W, Chaiken I.
    Biochemistry; 1999 Jul 20; 38(29):9405-16. PubMed ID: 10413516
    [Abstract] [Full Text] [Related]

  • 14. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A, Ladha A, Cohen EA, Menezes J.
    Virology; 1993 Feb 20; 192(2):447-57. PubMed ID: 8421893
    [Abstract] [Full Text] [Related]

  • 15. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.
    Corbeau P, Haran M, Binz H, Devaux C.
    Mol Immunol; 1994 Jun 20; 31(8):569-75. PubMed ID: 8196669
    [Abstract] [Full Text] [Related]

  • 16. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F, Fenoglio D, Valle MT, Li Pira G, Kunkl A, Ferraris A, Saverino D, Lancia F, Mortara L, Lozzi L.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul 01; 9(3):227-37. PubMed ID: 7540488
    [Abstract] [Full Text] [Related]

  • 17. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H, Otaka A, Murakami T, Ishihara T, Ibuka T, Waki M, Matsumoto A, Yamamoto N, Fujii N.
    Biochem Biophys Res Commun; 1996 Feb 15; 219(2):555-9. PubMed ID: 8605026
    [Abstract] [Full Text] [Related]

  • 18. Is the V3 loop involved in HIV binding to CD4?
    Dettin M, Ferranti P, Scarinci C, Picariello G, Di Bello C.
    Biochemistry; 2003 Aug 05; 42(30):9007-12. PubMed ID: 12885233
    [Abstract] [Full Text] [Related]

  • 19. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L, Zolla-Pazner S, Gorny MK, Cheng-Mayer C.
    Virology; 1997 Mar 17; 229(2):360-9. PubMed ID: 9126249
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 gp 120 blocks jacalin-induced proliferative response in CD4+ T cells: jacalin as a useful surrogate marker for qualitative and quantitative deficiency of CD4+ T cells in HIV-1 infection.
    Tamma SM, Oyaizu N, McCloskey TW, Kalyanaraman VS, Pahwa S.
    Clin Immunol Immunopathol; 1996 Sep 17; 80(3 Pt 1):290-7. PubMed ID: 8811050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.